Jubilant Pharmova announced that the United States Food and Drug
Administration (USFDA) has concluded an eight day audit of the Jubilant HollisterStier LLC's contract manufacturing facility located in Spokane, Washington (USA). The USFDA has issued 3 observations pursuant to the completion of audit. The company will submit an action plan on the observations.
Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma, Singapore, a wholly owned subsidiary of the company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
